Amomonpon, Marjie .

HRN: 11-13-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2025
CEFUROXIME 500MG (TAB)
04/25/2025
05/01/2025
PO
500 Mg
BID
Sp RMLE And Repair, Thinly MSAF
Waiting Final Action 
04/26/2025
CEFUROXIME 1.5GM (VIAL)
04/26/2025
04/27/2025
IV
1.5g
Q8h X 3 Doses
T/c Endometritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: